FDA Reports Hospitalizations & Deaths Linked to CAR-T Cell Immunotherapies: Potential for Imminent Regulatory Action

This could be a gamechanger!!!

TrialSite News drops a bombshell

This article below drew my attention last week. Having just circled back and read it again, it could be a gamechanger:

FDA Reports Hospitalizations & Deaths Linked to CAR-T Cell Immunotherapies: Potential for Imminent Regulatory Action

I’ve picked out the salient points so that subscribers to Inside Pharma can get the pictu…